[ad_1]
According to Jornal de Notícias who quotes an Infarmed report, "the first months of 2018 already anticipate a new escalation (30 million more than at the same time)". Oncology, rheumatoid arthritis, psoriasis and paramyloidosis are the diseases that cause a greater increase in expenditure with drugs.
Of the 1141 million euros spent on drugs in National Health Service hospitals, 45% are absorbed by hospitals in the Lisbon region and the Tagus Valley. The northern region has a weight of 32 percent, the center 17 percent. Alentejo and Algarve account for about three percent each.
The Infarmed report also reveals that it is the northern region that has contributed the most to the increase in spending, with another 20 million. It follows the Lisbon region and the Tagus Valley with another 20 million.
In the hospitals of São João in Porto, University of Coimbra, North Lisbon and Lisbon Center, the bill with drugs has increased by 23 million euros compared to 2016, "totaling more than 600 million. 39; euros. "
The North Lisbon Hospital Center, which includes the hospitals of Santa Maria and Pulido Valente, is the one that spends the most on drugs (155.5 million). Expenditure on drugs for hepatitis C is not included in the report.
The document also states that it is within the framework of the IPO (Lisbon, Porto and Coimbra) that spending increased more sharply in percentage (12.6%). This value is related to the cost of new drugs for the treatment of oncological diseases.
Oncological drugs cost, in 2017, 284 million euros, or 13.7% more than during the same period last year.
On the other hand, spending on drugs for the treatment of the human immunodeficiency virus (HIV) fell by 12.3 million euros to reach a total of 215 million.
Medications for rheumatoid arthritis and psoriasis, chronic diseases with increasingly expensive treatments, represent a bill of 120 million euros.
Spending for orphan drugs also increased, in 2017 the bill was 102 million euros, 19 million more than in 2016.
Source link
